Spectral properties of pro-multimodal imaging agents derived from a NIR dye and a metal chelator

Photochemistry and Photobiology

Volumn 81, Issue 6, 2005, Pages 1499-1504

  Zhang, Zongren ^a   Achilefu, Samuel ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; CONTRAST MEDIUM; COPPER; FLUORESCENT DYE; INDIUM;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; NEAR INFRARED SPECTROSCOPY;

CHELATING AGENTS; CONTRAST MEDIA; COPPER; FLUORESCENT DYES; INDIUM; MOLECULAR STRUCTURE; SPECTROSCOPY, NEAR-INFRARED;

EID: 29644440786     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2005-06-08-RA-568     Document Type: Article

References (16)

1. Benaron, D. A. (2002) The future of cancer imaging. Cancer Metastasis Rev. 21, 45-78.
2. Glasspool, R. M. and T. R. J. Evans (2000) Clinical imaging of cancer metastasis. Eur. J. Cancer 36, 1661-1670.
3. Kelly, K. A., J. R. Allport, A. Tsourkas, V. R. Shinde-Patil, L. Josephson and R. Weissleder (2005) Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 96, 327-336.
4. Morawski, A. M., G. A. Lanza and S. A. Wickline (2005) Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 16, 89-92.
5. Schellenberger, E. A., D. Sosnovik, R. Weissleder and L. Josephson (2004) Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 15, 1062-1067.
6. Manning, H. C., T. Goebel, R. C. Thompson, R. R. Price, H. Lee and D. J. Bornhop (2004) Targeted molecular imaging agents for cellular-scale bimodal imaging. Bioconjug. Chem. 15, 1488-1495.
7. Moore, A., Z. Medarova, A. Potthast and G. P. Dai (2004) In vivo targeting of underglycosylated muc-1 tumor antigen using a multimodal imaging probe. Cancer Res. 64, 1821-1827.
8. Zhang, Z. and S. Achilefu (2004) Synthesis and evaluation of polyhydroxylated near-infrared carbocyanine molecular probes. Org. Lett. 6, 2067-2070.
9. Achilefu, S., A. Srinivasan, M. A. Schmidt, H. N. Jimenez, J. E. Bugaj and J. L. Erion (2003) Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors. J. Med. Chem. 46, 3403-3411.
10. Zhang, Z. R., K. Liang, S. Bloch, M. Berezin and S. Achilefu (2005) Monomolecular multimodal fluorescence-radioisotope imaging agents. Bioconjugate Chem. 16, 1232-1239.
11. 1-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy. Bioconjug. Chem. 13, 721-728.
12. Lewis, J. S., R. Laforest, M. R. Lewis and C. J. Anderson (2000) Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogues in a tumor-bearing rat model. Cancer Biother. Radiopharm. 15, 593-604.
13. Anderson, C. J., T. S. Pajeau, W. B. Edwards, E. L. C. Sherman, B. E. Rogers and M. J. Welch (1995) In vitro and in vivo evaluation of copper-64-labeled octreotide conjugates. J. Nucl. Med. 36, 2315-2325.
14. Cotton, F. A (1990) The ligand field theory. In Chemical Applications of Group Theory, 3rd ed. pp. 287-288. Wiley, New York.
15. Tachibana, Y., N. Kihara and T. Takata (2004) Asymmetric benzoin condensation catalyzed by chiral rotaxanes tethering a thiazolium salt moiety via the cooperation of the component: can rotaxane be an effective reaction field? J. Am. Chem. Soc. 126, 3438-3439.
16. Achilefu, S., R. B. Dorshow, J. E. Bugaj and R. Rajagopalan (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Investig. Radiol. 35, 479-485.